Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial Gene Expression with rFSH +/- rLH in Poor Responders
NCT05405686Phase 4Withdrawn
- Sponsor
- CRG UZ Brussel
- Start
- May 2023
- Primary completion
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of lutropin alfa in poor ovarian response (POR), sponsored by CRG UZ Brussel. Planned start May 2023; status: withdrawn.
02
Drugs
lutropin alfa
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT05405686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05405686.